Bayhill Therapeutics and the Juvenile Diabetes Research Foundation Announce Research Collaboration for the Clinical Development of a Novel Immunotherapeutic DNA Vaccine for Type 1 Diabetes

View Full Size 

Download

• Thumbnail GIF, 120x37, 1.4 KB
• Preview JPEG, 144x45, 1.8 KB
• Small JPEG, 864x270, 13.6 KB
• Full Size JPEG, 864x270, 38.3 KB